Acute Bipolar Manic Episode Clinical Trial
Official title:
European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes Treated With Immediate Release Quetiapine or Extended Release Quetiapine
This study is being carried out to find out how patients suffering from the acute manic phase of bipolar disease are currently managed with Quetiapine Immediate Release (IR) or Quetiapine Extended Release (XR) in the hospital setting in real life practice, including length of stay.
Status | Completed |
Enrollment | 1280 |
Est. completion date | March 2011 |
Est. primary completion date | March 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients diagnosed with Bipolar Disorder (ICD-10). - Admitted for acute bipolar manic episode from 1st October 2009 to 1st October 2010 - Patients treated with quetiapine IR or quetiapine XR during the hospitalization period. Exclusion Criteria: - Patients in which BD is not the main reason for hospitalization - Patients admitted for acute bipolar mania episodes but finally diagnosed with mixed or bipolar disorder not otherwise specified (NOS) episodes - Patients receiving both quetiapine IR and XR during the same hospitalization period. |
Observational Model: Cohort, Time Perspective: Retrospective
Country | Name | City | State |
---|---|---|---|
Belgium | Research Site | Assebroek | |
Belgium | Research Site | Bertrix | |
Belgium | Research Site | Brugge | |
Belgium | Research Site | Elsene | |
Belgium | Research Site | Gent | |
Belgium | Research Site | Godinne | |
Belgium | Research Site | Koksijde | |
Belgium | Research Site | Malle | |
Belgium | Research Site | Marchienne-au-Pont | |
Belgium | Research Site | Montignies-Sur-Sambre | |
Belgium | Research Site | Ottignies | |
Belgium | Research Site | Overpelt | |
Belgium | Research Site | Roeselaere | |
Croatia | Research Site | Split | |
Croatia | Research Site | Zagreb | |
Denmark | Research Site | Augustenborg | |
Denmark | Research Site | Bispebjerg | |
Denmark | Research Site | Br?nderslev | |
Denmark | Research Site | Odense | |
Finland | Research Site | Helsingin Kaupunki | |
Finland | Research Site | Jyv?skyl? | |
Finland | Research Site | Kellokoski | |
Finland | Research Site | Tammisaari | |
Germany | Research Site | Berlin | |
Germany | Research Site | Bielefeld | Niedersachsen |
Germany | Research Site | Bochum | Nordrhein-Westfalen |
Germany | Research Site | Cham | Bayern |
Germany | Research Site | Greifswald | Mecklenburg- Vorpommern |
Germany | Research Site | Hildesheim | Niedersachsen |
Germany | Research Site | Liebenburg | Niedersachsen |
Germany | Research Site | Neu?tting | Bayern |
Germany | Research Site | Regensburg | Bayern |
Germany | Research Site | Ulm | Baden-W?rttemberg |
Germany | Research Site | W?rzburg | Bayern |
Germany | Research Site | Wasserburg am Inn | Bayern |
Italy | Research Site | Ascoli Piceno | |
Italy | Research Site | Bologna | |
Italy | Research Site | Ceglie Messapica | Brindisi |
Italy | Research Site | Conegliano | Treviso |
Italy | Research Site | Cosenza | |
Italy | Research Site | Cuneo | |
Italy | Research Site | Ferrara | |
Italy | Research Site | Foggia | |
Italy | Research Site | Lamezia Terme | Catanzaro |
Italy | Research Site | Loc. S. Marciano (Sora) | Frosinone |
Italy | Research Site | Mestre | |
Italy | Research Site | Pisa | |
Italy | Research Site | Roma | |
Italy | Research Site | S. Agata Militello | Messina |
Italy | Research Site | San Pietro Vernotico | Brindisi |
Italy | Research Site | Sassari | |
Italy | Research Site | Teramo | |
Turkey | Research Site | Adana | |
Turkey | Research Site | Ankara | |
Turkey | Research Site | Ayd?n | |
Turkey | Research Site | Bolu | |
Turkey | Research Site | Diyarbakir | |
Turkey | Research Site | Elazig | |
Turkey | Research Site | Erzurum | |
Turkey | Research Site | Istanbul | |
Turkey | Research Site | Kayseri | |
Turkey | Research Site | Konya | |
Turkey | Research Site | Manisa | |
Turkey | Research Site | Samsun | |
Turkey | Research Site | Sanliurfa | |
Turkey | Research Site | Sivas | |
Turkey | Research Site | Trabzon | |
Turkey | Research Site | Zonguldak | |
United Kingdom | Research Site | Bradford | Yorkshire |
United Kingdom | Research Site | Bury St Edmunds | |
United Kingdom | Research Site | Cannock | Staffordshire |
United Kingdom | Research Site | Chertsey | Surrey |
United Kingdom | Research Site | Coventry | |
United Kingdom | Research Site | Dartford | Kent |
United Kingdom | Research Site | Ealing | London |
United Kingdom | Research Site | Hull | |
United Kingdom | Research Site | Leeds | |
United Kingdom | Research Site | Leicester | |
United Kingdom | Research Site | London | |
United Kingdom | Research Site | Newcastle (Upon Tyne) | |
United Kingdom | Research Site | Norwich | Norfolk |
United Kingdom | Research Site | Prescot | Merseyside |
United Kingdom | Research Site | Pulborough | West Sussex |
United Kingdom | Research Site | Taunton | Somerset |
United Kingdom | Research Site | Winsford | Cheshire |
United Kingdom | Research Site | Wolverhampton | West Midlands |
Lead Sponsor | Collaborator |
---|---|
AstraZeneca |
Belgium, Croatia, Denmark, Finland, Germany, Italy, Turkey, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Length of hospital stay | No | ||
Secondary | Use of resources | No | ||
Secondary | Treatments used | No | ||
Secondary | Demographics | No |